Skip to main content
NETEC logo - link to main NETEC page

Novel Coronavirus (COVID-19)

About the COVID-19 novel Coronavirus

Follow the links below to find resources related to COVID-19 for all facilities, including the NETEC webinar series, PPE use and conservation guidance documents, education and training resources, preparedness resources, research on respiratory pathogens and airborne transmission, clinical guidance documents, documents on ambulatory PPE, and other research resources. Click here for items on COVID-19 and pediatrics. Scroll for the COVID-19 map, key updates, and new NETEC resources. You can go to the WHO COVID-19 pages and the CDC COVID-19 pages for additional resources.

New NETEC Resources:

Updates and Map

Find more information on Coronavirus on the Lancet's Coronavirus page. See updates on COVID-19 on the WHO Novel Coronavirus (COVID-19) page with Situation Reports and Disease Outbreak News, and see the updated Geographical distribution of COVID-19 cases within China and globally on the European Centre for Disease Prevention and Control page. Map below created by Johns Hopkins (if the map does not load below, you can view it on the Johns Hopkins page).

jhu_map_image.png
Click for Mobile Map of COVID-19 Data by JHU.

Key updates:

  • FDA authorizes Pfizer COVID-19 vaccine EUA for adolescents 12-15 years of age (FDA).
  • The FDA and CDC lifted the J&J vaccine pause April 23, following a thorough safety review (FDA, CDC). They had recommended a pause April 13 on the J&J vaccine to review side effects (FDA). The FDA approved the Janssen/Johnson & Johnson vaccine Feb. 27, 2021 EUA in the USA (FDA).
  • The U.S. State Department issued and updated more than 150 Level 4: Do Not Travel advisories to countries on April 20-21, 2021, as well as more than 50 Level 2 and Level 3 advisories due to COVID-19 (U.S. State Department).
  • On Feb. 9, 2021, the FDA issued an Emergency Use Authorization (EUA) for bamlanivimab and etesevimab administered together for the treatment of mild to moderate COVID-19 in adults and pediatric patients (12-years-old+, weighing at least 40 kg) (FDA).
  • New COVID-19 variants are circulating globally. Find out more from the CDC.
  • Follow the number of vaccination doses distributed and administered in the USA on the CDC's dashboard. The Moderna developed vaccine was given FDA approval on Friday December 18, 2020 (FDA). The CDC signed the recommendation to use Pfizer’s vaccine on December 12, 2020 (CDC). Development continues to advance on coronavirus vaccines with over two dozen in human trials. Follow the development of each with the Coronavirus Vaccine Tracker managed by The New York Times.
  • The NIH COVID-19 Treatment Guidelines summarizes clinical data for treatment of COVID-19 (CDC).
  • On 31 December 2019 the WHO China Country Office was informed of cases of pneumonia of unknown etiology (unknown cause) in Wuhan City, China. A novel coronavirus (2019-nCoV) was identified by Chinese authorities on 7 January 2020 (WHO). On 11 February the name of the virus was announced as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and of the disease as coronavirus disease (COVID-19) (WHO).

CDC Novel Coronavirus Updates

Novel Coronavirus (COVID-19)

Share this page: